Tempo: 150.0

Novo Nordisk is shipping more introductory doses of its blockbuster weight-loss drug Wegovy in the US as it grapples with supply constraints and competition from Eli Lilly & Co. CEO Lars Fruergaard Jorgensen says the company will continue to ramp up supply of its popular weight-loss drug "gradually." He spoke with Bloomberg's Katie Greifeld and Romaine Bostick. 

Novo Nordisk is shipping more introductory doses of its blockbuster weight-loss drug Wegovy in the US as it grapples with supply constraints and competition from Eli Lilly &amp; Co. CEO Lars Fruergaard Jorgensen says the company will continue to ramp up supply of its popular weight-loss drug "gradually." He spoke with Bloomberg's Katie Greifeld and Romaine Bostick.

Listen for top interviews from Bloomberg News. 

Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics, technology, foreign relations, sports and entertainment.

Listen to top interviews from Bloomberg News.

Bloomberg Talks

Novo Nordisk CEO Talks Weight Loss Drug Supply

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/7a30995e-df80-4f8d-b9d2-b164014b2e58/transcript

Marc Morial, President and CEO of the National Urban League, talks special report on black consumer spending and America's priorities. He talks to Bloomberg's Carol Massar and Tim Stenovec.

Marc Morial, President and CEO of the National Urban League, talks special report on black consumer spending and America's priorities. He talks to Bloomberg's Carol Massar and Tim Stenovec.

National Urban League CEO Marc Morial Talks Workforce for Black Americans

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/6e8a086d-6690-41e0-826e-b49f01759e64/transcript

In an exclusive interview, PGA Tour boss Brian Rolapp said there's no merger and no conversations with LIV Golf, stating the PGA Tour has been concentrated on its own product. Speaking to Tom Keene and Scarlet Fu on Bloomberg Money, Rolapp said the PGA Tour has been mainly focused on improving its product, introducing a new format with a two-tier series and increased player compensation to counter the impact of LIV Golf.

In an exclusive interview, PGA Tour boss Brian Rolapp said there's no merger and no conversations with LIV Golf, stating the PGA Tour has been concentrated on its own product. Speaking to Tom Keene and Scarlet Fu on Bloomberg Money, Rolapp said the PGA Tour has been mainly focused on improving its product, introducing a new format with a two-tier series and increased player compensation to counter the impact of LIV Golf.

PGA Tour CEO Brian Rolapp Talks End of LIV Golf Tie-Up Talks 

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/409e3fbc-b0a8-465f-baa3-b49f014e36c1/transcript

Lyft CEO David Risher discusses the company's growth compared to Waymo, its plans to expand internationally and where Lyft is focused internally. He speaks with Ed Ludlow on "Bloomberg Tech."

Lyft CEO David Risher discusses the company's growth compared to Waymo, its plans to expand internationally and where Lyft is focused internally. He speaks with Ed Ludlow on "Bloomberg Tech."

Lyft CEO David Risher Talks Company Expansion

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/262adc35-4609-49d1-82ea-b49f011ced35/transcript

Novo Nordisk CEO Talks Weight Loss Drug Supply

In 1 playlist(s)

Bloomberg Talks

Social links

Follow podcast

Recent clips